Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials
Joel Yeh Siang Chen, Damien Chua, Carissa Odelia Lim, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 158-158
Open Access | Times Cited: 16

Showing 16 citing articles:

Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies
Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 454-499
Open Access | Times Cited: 30
Molecular Mechanisms of Fucoxanthin in Alleviating Lipid Deposition in Metabolic Associated Fatty Liver Disease
Shouxing Yang, Jinhai Li, Liping Yan, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 18, pp. 10391-10405
Closed Access | Times Cited: 15
BI-3231, an enzymatic inhibitor of HSD17B13, reduces lipotoxic effects induced by palmitic acid in murine and human hepatocytes
Lucia Alcober‐Boquet, Nico Kraus, Lisa Sophie Huber, et al.
AJP Cell Physiology (2024) Vol. 326, Iss. 3, pp. C880-C892
Closed Access | Times Cited: 4
The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment
Eleni Michalopoulou, J Thymis, Stamatios Lampsas, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 428-428
Open Access
ILF3 inhibits p-AMPK expression to drive non-alcoholic fatty liver disease progression
Ting Zhan, Jiaxi Liu, Min Huang, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 2
Closed Access
Combination therapy with vitamin E and ertugliflozin in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a randomized clinical trial
Adil Khaliq, Haroon Badshah, Yasar Shah
Irish Journal of Medical Science (1971 -) (2025)
Closed Access
Investigating Fabry disease - some lessons learned
Raphael Schiffmann
Rare Disease and Orphan Drugs Journal (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 2
Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease
Amrita Kandel, Poonam Pant, Sushila Todi, et al.
SAGE Open Medicine (2024) Vol. 12
Open Access | Times Cited: 2
Genomics of human NAFLD: Lack of data reproducibility and high interpatient variability in drug target expression as major causes of drug failures
Shifang Tang, Jürgen Borlak
Hepatology (2024) Vol. 80, Iss. 4, pp. 901-915
Open Access | Times Cited: 2
Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
Seogsong Jeong, Woo-Young Shin, Yun Hwan Oh
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Marine-Derived Phosphoeleganin and Its Semisynthetic Derivative Decrease IL6 Levels and Improve Insulin Signaling in Human Hepatocellular Carcinoma Cells
Ayewa L. Agognon, Marcello Casertano, Alessio Vito, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6039-6039
Open Access | Times Cited: 1
Synthesis of vitamin D3 loaded ethosomes gel to cure chronic immune-mediated inflammatory skin disease: physical characterization, in vitro and ex vivo studies
Yasir Mehmood, Hira Shahid, Shabbir Ahmed, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Prospects of using sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients with metabolic-associated fatty liver disease (MAFLD)
Iryna Kostitska, Nadia Protas, Liliia Petrovska
Diabetes Obesity Metabolic Syndrome (2023), Iss. 5, pp. 8-37
Open Access | Times Cited: 2
Probabilistic Scatter Plots for visualizing carbohydrate and lipid metabolism states in Non-Alcoholic Fatty Liver Disease
Jialin Zhou, Tengxiao Liang, Fangliang Xing, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 6, pp. 102365-102365
Open Access
Dark Tea Wine Protects Against Metabolic Dysfunction-Associated Steatotic Liver Disease In Vivo Through Activating the Nrf2/HO-1 Antioxidant Signaling Pathway
Xiaodong Zhai, Suyang Li, Tongsheng Wang, et al.
Journal of Medicinal Food (2024) Vol. 27, Iss. 10, pp. 912-921
Closed Access
Gastrodia elata rhizoma ameliorates thioacetamide-induced liver injury in dogs
Hye-Bin Yoon, Jeong-Hwi Cho, Jung Soo Kim, et al.
Journal of Advanced Veterinary and Animal Research (2023) Vol. 10, Iss. 2, pp. 144-144
Open Access | Times Cited: 1
Page 1

Scroll to top